DRKS00023387

Effects of hypoxia exposure on the human circadian clock

Deutsches Zentrum für Luft- und Raumfahrt (DLR)Institut für Luft- und Raumfahrtmedizin Schlaf und HumanfaktorenProf. Dr. Daniel AeschbachLinder Höhe51147 KölnGermany·Deutsches Register Klinischer StudienRecruitment Completed
Study focus
Disease/Condition
None ;Healthy volunteers
Study type
Interventional
Sponsor & location
Primary sponsor
Deutsches Zentrum für Luft- und Raumfahrt (DLR)Institut für Luft- und Raumfahrtmedizin Schlaf und HumanfaktorenProf. Dr. Daniel AeschbachLinder Höhe51147 KölnGermany
Location
Germany
Timeline & enrollment
Phase
N/A
Start date
N/A
End date
N/A
Summary

The suprachiasmatic nucleus dictates our internal circadian rhythms and is entrained to the 24-h rhythm via exposure to light and other zeitgebers (time cues). The master clock maintains phase coherence in peripheral cells through systemic cues such as feeding-fasting and temperature cycles. Misalignment of the circadian rhythm is associated with various negative health consequences like cardiovascular disease, depression, mood, accidents and disturbed sleep.

ICD-10 classifications
Healthy person accompanying sick personRoutine general health check-up of armed forcesRoutine general health check-up of sports teamsRoutine general health check-up of inhabitants of institutions
Data source
Registry
Deutsches Register Klinischer Studien
Trial ID
DRKS00023387
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for DRKS00023387 through Pure Global AI's free database. This phase not specified trial is sponsored by Deutsches Zentrum für Luft- und Raumfahrt (DLR)Institut für Luft- und Raumfahrtmedizin Schlaf und HumanfaktorenProf. Dr. Daniel AeschbachLinder Höhe51147 KölnGermany and is currently Recruitment Completed. The study focuses on None ;Healthy volunteers.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Deutsches Register Klinischer Studien data, helping medical device and pharmaceutical companies navigate clinical research efficiently.